1. TeitelbaumD MeshorerA HirshfeldT ArnonR SelaM.Therapeutic copolymer. US Patent 3849550;1974.
2. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. FDA:2019.https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm Accessed 08.2019
3. European Medicines Agency.Human Medicines Evaluation Division. List of nationally authorised medicinal products. EMA/537197/2018; July 12 2018.
4. Draft Guidance on Glatiramer Acetate. FDA.https://www.accessdata.fda.gov/drugsatfda_docs/psg/Glatiramer%20acetate_subcutaneous%20Injection_NDA%20020622_RV07-18.pdf
5. European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. EMA/CHMP/771815/2011; Rev. February 2015.http://www.ema.europa.eu. Accessed 08.2019